• Non ci sono risultati.

5 Disorders of Histidine Metabolism Nenad Blau

N/A
N/A
Protected

Academic year: 2021

Condividi "5 Disorders of Histidine Metabolism Nenad Blau"

Copied!
1
0
0

Testo completo

(1)

5 Disorders of Histidine Metabolism

Nenad Blau

5.1 Introduction

Histidinemia, urocanase deficiency, and formiminotransferase deficiency are harmless disorders, although treatment might be considered in a histidine- mic infant who is symptomatic (< 1%; Levy et al. 2001). A few patients with speech impairment were found to be mentally retarded. It appears that clinical abnormalities in these patients are coincidental.

5.2 Nomenclature

No. Disorder Definitions/comment Gene Symbol OMIM No.

5.1 Histidinemia Histidine ammonia-lyase

deficiency

HAL 235800

5.2 Urocanase deficiency 276880

5.3 Formiminotransferase deficiency FTCD 229100

5.3 Treatment and Follow-up Generally no treatment required.

I Symptomatic Patients

5.1 Histidinemia Low-His diet

5.3 Formiminotransferase deficiency Folinic acid, 15 mg/day

References

1. Levy HL, Taylor RG, McInnes RR (2001) Disorders of histidine metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, 8th edn.: McGraw-Hill, New York pp 1807–1820

Riferimenti

Documenti correlati

Youdim MB, Yehuda S (2000) The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine- opiate system. Cell Mol Biol

Cystathionine beta synthase (C β S) deficiency, classic homocystinuria, results in elevated levels of circulating Hcy and methionine, S-adenosylmethionine and S-adenosyl

14.2 CPT1 (infantile/childhood form) Prognosis uncertain, with high risk of severe sequalae or exitus during intercurrent decompensations 14.3 CAC (infantile/childhood form)

Disorders of Fructose Metabolism/Deficiencies of Gluconeogenesis 169 Patients with FDP (disorder 15.5) and PC, (disorder 15.6) depend for the main- tenance of normal blood

4–12 months Weekly – Fortnightly 1–3 monthly Check 1–2 years Weekly – Fortnightly 2–6 monthly. 2–3 years Weekly – Fortnightly 2–6

Eugster EA, DiMeglio LA, Wright JC, Freidenberg GR, Seshadri R, Pescovitz OH (2001) Height outcome in congenital adrenal hyperplasia caused by 21-hydroxylase deficiency:.

Perinatal hemochromatosis (also known as neonatal hemochromatosis or neona- tal iron-storage disorder) comprises a group of disorders with similar clinical appearance: neonatal

Barcia JP, Strife CF, Langman CB (1997) Infantile hypophosphatasia: treatment options to control hypercalcemia, hypercalciuria, and chronic bone demineralization. Girschick HJ,